Oscar Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	550.93	-442.9	26.12	-270.59	-609.55	-571.43
Depreciation & Amortization	28.24	28.89	32.15	30.69	15.28	14.61
Stock-Based Compensation	75.19	87.65	109.82	159.68	112.33	86.3
Other Adjustments	13.72	-37.79	-28.76	0.14	7.29	41.08
Change in Receivables	-110.17	-93.22	-127.18	-15.47	-90.25	-76.46
Changes in Accounts Payable	3,386	205.49	152.77	-29.18	57.81	98.62
Changes in Accrued Expenses	346.8	98.66	390.74	28.26	424.15	201.67
Changes in Unearned Revenue	98.02	91.81	8.47	-13.08	3.95	3.14
Changes in Other Operating Activities	-41.93	1,156	414.06	-162.62	459.34	20.73
Operating Cash Flow	4,419	1,095	978.19	-272.16	380.35	-181.75
Operating Cash Flow Growth	257.99%	11.93%	-	-	-	-
Capital Expenditures	-38.63	-36.37	-27.9	-25.58	-29.01	-25.89
Purchases of Investments	-5,349	-1,014	-2,134	-836.98	-1,193	-1,810
Proceeds from Sale of Investments	2,060	804.96	770.04	1,442	994.08	1,055
Other Investing Activities	4.36	4.28	3.93	-2.28	1.12	6.68
Investing Cash Flow	-3,323	-241.06	-1,387	577.19	-226.52	-774.52
Long-Term Debt Issued	-	410	-	-	305	-
Long-Term Debt Repaid	-	-	-	-	-	-153.17
Net Long-Term Debt Issued (Repaid)	-	410	-	-	305	-153.17
Issuance of Common Stock	55.64	55.03	68.39	3.96	1.3	1,407
Repurchase of Common Stock	-13.67	-4.04	-	-	-	-
Net Common Stock Issued (Repurchased)	41.98	51	68.39	3.96	1.3	1,407
Other Financing Activities	-27.82	-61.79	-	2.49	-5.19	-15.21
Financing Cash Flow	381.9	399.21	68.39	6.45	301.11	1,239
Net Cash Flow	1,477	1,253	-340.85	311.47	454.94	282.45
Free Cash Flow	4,380	1,058	950.3	-297.74	351.34	-207.63
Free Cash Flow Growth	264.51%	11.38%	-	-	-	-
FCF Margin	28.59%	9.05%	10.35%	-5.08%	8.86%	-11.29%
Free Cash Flow Per Share	14.53	4.03	3.57	-1.34	1.65	-1.16
Levered Free Cash Flow	4,329	1,512	995.72	-442.23	630.25	-412.91
Unlevered Free Cash Flow	4,366	1,143	1,015	-410.02	342.16	-232.42

SEC Filings: 10-K · 10-Q